Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is C  [Clear All Filters]
2021
Lin LM, Huang G, Sigurdsson A, Kahler B. Clinical cell-based vs cell-free regenerative endodontics: Clarification of concept and term. Int Endod J. 2021.
Basquiera AL, García MJ, Rolón JMartínez, Olmedo J, Laviano J, Burgos R, Caeiro G, Remaggi G, Raña P, Paoletti M, et al. Clinical characteristics and evolution of hematological patients and COVID-19 in Argentina: a report from the Argentine Society of Hematology. Medicina (B Aires). 2021;81(4):536-545.
Mu S, Sha C, Ren S, Xiang D. Clinical Characteristics and Influence Factor Analysis of ABO Typing Discrepancy Among Patients in a Tertiary Hospital. Clin Lab. 2021;67(11).
Facchin G, Candoni A, Lazzarotto D, Zannier MElena, Peghin M, Sozio E, Pellegrini N, Filì C, Sartor A, Tascini C, et al. Clinical characteristics and outcome of 125 polymicrobial bloodstream infections in hematological patients: an 11-year epidemiologic survey. Support Care Cancer. 2021.
Sharma A, Bhatt NS, St Martin A, Abid MBilal, Bloomquist J, Chemaly RF, Dandoy C, Gauthier J, Gowda L, Perales M-A, et al. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study. Lancet Haematol. 2021.
Limaye S, Limaye V. Clinical Characteristics of Myositis Associated with Graft-Versus-Host Disease. Curr Rheumatol Rep. 2021;23(5):30.
Huang Y, Hu Z, Hu D, Quan Z, Zhou X, Fan G, Chen X, Liu X, Zhang Z, Chen G, et al. Clinical characteristics, risk factors and cardiac manifestations of cancer patients with COVID-19. J Appl Physiol (1985). 2021.
Wudhikarn K, Padrnos L, Lasho T, LaPlant B, Kumar S, Dispenzieri A, Lacy M, Rajkumar SV, Gertz M, Mangaonkar AA, et al. Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post-autologous stem cell transplantation lenalidomide maintenance therapy. Am J Hematol. 2021.
Bolia IK, Bougioukli S, Hill WJ, Trasolini NA, Petrigliano FA, Lieberman JR, Weber AE. Clinical Efficacy of Bone Marrow Aspirate Concentrate Versus Stromal Vascular Fraction Injection in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis. Am J Sports Med. 2021:3635465211014500.
Cristiano G, Nanni J, Sartor C, Parisi S, Marconi G, Barbato F, Arpinati M, Bonifazi F, Curti A, Cavo M, et al. Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement. Acta Haematol. 2021:1-5.
Steinbügl M, Nemes K, Johann P, Kröncke T, Tüchert S, da Costa MJoao Gil, Ebinger M, Schüller U, Sehested A, Hauser P, et al. Clinical evidence for a biological effect of epigenetically active decitabine in relapsed or progressive rhabdoid tumors. Pediatr Blood Cancer. 2021:e29267.
Ercelen NO, Pekkoc-Uyanik KCigdem, Alpaydin N, Gulay GRasit, Simsek M. Clinical experience on umbilical cord mesenchymal stem cell treatment in 210 severe and critical COVID-19 cases in Turkey. Stem Cell Rev Rep. 2021.
Zhou F, Wang R, Yu Z, Li S, Li X. [Clinical features and genetic analysis of a child with late-onset immune dysregulation, polyendocrinopathy, enteropathy, X-Linked syndrome]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2021;38(3):255-259.
Prabahran AA, Koldej R, Chee L, Ritchie DS. Clinical features, pathophysiology and therapy of Poor Graft Function Post Allogeneic Stem Cell Transplantation. Blood Adv. 2021.
Aberer E, Sperr WR, Bretterklieber A, Avian A, Hadzijusufovic E, Kluin-Nelemans HC, Elberink HOude, van Anrooij B, Niedoszytko M, Lange M, et al. Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis (ECNM). J Invest Dermatol. 2021.
Morishita S, Ochiai T, Misawa K, Osaga S, Inano T, Fukuda Y, Edahiro Y, Ohsaka A, Araki M, Komatsu N. Clinical impacts of the mutational spectrum in Japanese patients with primary myelofibrosis. Int J Hematol. 2021.
Frank MH, Wilson BJ, Gold JS, Frank NY. Clinical Implications of colorectal cancer stem cells in the age of single-cell OMICs and targeted therapies. Gastroenterology. 2021.
Mohan M, Kendrick S, Szabo A, Yarlagadda NK, Atwal D, Pandey Y, Roy AMariam, Parikh R, Lopez J, Thanendrarajan S, et al. Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myeloma. Blood Adv. 2021.
Grimm J, Jentzsch M, Bill M, Backhaus D, Brauer D, Küpper J, Schulz J, Franke G-N, Vucinic V, Niederwieser D, et al. Clinical Implications of SRSF2 Mutations in AML Patients undergoing Allogeneic Stem Cell Transplantation. Am J Hematol. 2021.
Ng SWk, Murphy T, King I, Zhang T, Mah M, Lu Z, Stickle N, Ibrahimova N, Arruda A, Mitchell A, et al. A Clinical Laboratory-Developed LSC17 Stemness Score Assay for Rapid Risk Assessment of Acute Myeloid Leukemia Patients. Blood Adv. 2021.
Holtzman NG, Pavletic SZ. The clinical landscape of chronic graft-versus-host disease management in 2021. Br J Haematol. 2021.
Rahman M, Dutta P, Agarwala P, Ikram S, Ahsan E, Shourav MManjurul I, Riviere-Cazaux C, Abuleil A, Bhorkar AMilind, Reza RRahman, et al. Clinical Manifestation, Management and Prognosis of Clear Cell Meningioma: An Evidence-Based Review. Int J Neurosci. 2021:1-8.
Oh J, Garabedian E, Fuleihan R, Cunningham-Rundles C. Clinical Manifestations and Outcomes of Activated Phosphoinositide 3-Kinase δ Syndrome from the USIDNET Cohort. J Allergy Clin Immunol Pract. 2021.
Shi YY, Zhang GX, He Y, Han MZ, Feng SZ, Zhang RL, Jiang EL. [Clinical outcomes of 31 patients with acute leukemia receiveing modified conditioning regimen incorporating cladribine for autologous hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2021;42(9):763-767.
Patel P, Robinson PD, Baggott C, Gibson P, Ljungman G, Massey N, Ottaviani G, Phillips R, Revon-Rivière G, Treister N, et al. Clinical practice guideline for the prevention of oral and oropharyngeal mucositis in pediatric cancer and hematopoietic stem cell transplant patients: 2021 update. Eur J Cancer. 2021;154:92-101.

Pages